Skip to main content

Table 1 Patient and tumour characteristics

From: Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy

Characteristics n (%)

GEMOX (n = 44)

Gem/Carb (n = 20)

p

n (%)

n (%)

 

Year of diagnosis

2004-2010

1998-2003

 

Gender, no (%)

   

 Male

29 (66)

9 (45)

0.17

 Female

15 (34)

11 (55)

 

Age

   

 <=67

19 (43)

12 (60)

0.28

 >67

25 (57)

8 (40)

 

ECOG PS, no. (%)

   

 0-1

34 (77)

14 (70)

0,75

 2-3

10 (23)

6 (30)

 

Primary tumour location

   

 Gallbladder

12 (27)

8 (40)

0.59

 Intrahepatic bile ducts

21 (48)

8 (40)

 

 Extrahepatic bile ducts

11 (25)

4 (20)

 

 Ampulla of Vater

0 (0)

0 (0)

 

Prior treatment for BTC

   

 Surgery

22 (50)

7 (37)

0.40

 Radiotherapy

5 (11)

4 (21)

 

Number of metastatic sites

   

 1

26 (59)

11 (58)

0.81

 >1

18 (41)

8 (42)

 
  1. Abbreviations: GEMOX gemcitabine and oxaliplatine combination regimen, Gem/Carb gemcitabine and carboplatin combination regimen, ECOG-PS Eastern Cooperative Oncology Group – Performance Status, BTC biliary tract carcinomas.